Glioblastma multiforme (GBM) is one of the most lethal primary brain tumors, with median survival of the patients, which is only slightly over one year. Researchers at Boston University School of Medicine (BUSM), in collaboration with researchers from the City of Hope, are looking toward novel therapeutic strategies for the treatment of GBM in the form of targeted therapies against a unique receptor, the interleukin-13 receptor (and) #945; chain variant 2 (IL13R (and) #945;2). ...
Read More
You have just read an article categorized health
titled Researchers Find Promise in Treatments for Glioblastma Multiforme.
Written by:
editor -
Thursday, October 2, 2014
There are currently no comments for "Researchers Find Promise in Treatments for Glioblastma Multiforme"
Post a Comment